Cargando…

Analysis of Glucose Responses to Automated Insulin Suspension With Sensor-Augmented Pump Therapy

OBJECTIVE: The advent of sensor-augmented pump therapy with a low-glucose suspend (LGS) function (Medtronic Paradigm Veo System), allowing insulin to be automatically suspended for up to 2 h when sensor glucose falls below a preset threshold, has the potential to reduce the duration of hypoglycemia....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ly, Trang T., Nicholas, Jennifer A., Retterath, Adam, Davis, Elizabeth A., Jones, Timothy W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379608/ https://www.ncbi.nlm.nih.gov/pubmed/22584133 http://dx.doi.org/10.2337/dc12-0052

Ejemplares similares

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
por: Jendle, Johan, et al.
Publicado: (2017)

The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes
por: O'Grady, Michael J., et al.
Publicado: (2012)

Performance of a predictive algorithm in sensor-augmented pump therapy in the prevention of hypoglycaemia
por: Abraham, Mary, et al.
Publicado: (2015)

Effectiveness of Automated Insulin Management Features of the MiniMed(®) 640G Sensor-Augmented Insulin Pump
por: Zhong, Alex, et al.
Publicado: (2016)

An Overview of Insulin Pumps and Glucose Sensors for the Generalist
por: McAdams, Brooke H., et al.
Publicado: (2016)

Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk
por: Choudhary, Pratik, et al.
Publicado: (2011)

Effect of exercise intensity and blood glucose level on glucose requirements to maintain stable glycaemia during exercise in individuals with type 1 diabetes
por: Vinutha, Shetty, et al.
Publicado: (2015)

Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 Diabetes
por: Joubert, Michael, et al.
Publicado: (2022)

Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
por: Ly, Trang T., et al.
Publicado: (2018)

Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose
por: Sherr, Jennifer L., et al.
Publicado: (2014)

“Let the Algorithm Do the Work”: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients
por: Biester, Torben, et al.
Publicado: (2017)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic Subjects Wearing a Sensor-Augmented Insulin Pump
por: Schiavon, Michele, et al.
Publicado: (2014)

Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment
por: Ortolani, Federica, et al.
Publicado: (2015)

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis
por: Buckingham, Bruce A., et al.
Publicado: (2015)

Advantages of sensor‐augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus
por: Imafuku, Hitomi, et al.
Publicado: (2023)

Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems
por: Marks, Brynn E., et al.
Publicado: (2021)

Frequency of Morning Ketosis After Overnight Insulin Suspension Using an Automated Nocturnal Predictive Low Glucose Suspend System
por: Beck, Roy W., et al.
Publicado: (2014)

Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
por: Buckingham, Bruce, et al.
Publicado: (2010)

Glycemic Control and Factors Impacting Treatment Choice in Tubeless Insulin Pump Users: A Survey of the T1D Exchange Glu Online Community
por: Layne, Jennifer E., et al.
Publicado: (2019)

Insulin pump therapy and glucose control during Ramadan fasting in an adolescent with type 1 diabetes: from an open-loop sensor-augmented pump therapy with predictive low-glucose management to an advanced hybrid closed-loop system
por: Wannes, Selmen, et al.
Publicado: (2023)

Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits
por: Pauley, Meghan E., et al.
Publicado: (2022)

Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy
por: Hussain, Tara, et al.
Publicado: (2017)

Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial
por: Moreno-Fernandez, Jesus, et al.
Publicado: (2016)

The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes
por: Lee, Yun Jeong, et al.
Publicado: (2020)

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
por: Roze, Stephané, et al.
Publicado: (2019)

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes
por: Grancini, V., et al.
Publicado: (2023)

Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery
por: de Bock, Martin I., et al.
Publicado: (2015)

Improving Epinephrine Responses in Hypoglycemia Unawareness With Real-Time Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes
por: Ly, Trang T., et al.
Publicado: (2011)

Outcomes and experiences of families with children with type 1 diabetes on insulin pumps through subsidised pump access programs in Western Australia
por: Fu, Vivian R., et al.
Publicado: (2023)

Glucose Control in Post-hemolytic-Uremic Syndrome Diabetes: A New Approach Offered by Sensor-Augmented Pump Therapy
por: Grancini, Valeria, et al.
Publicado: (2022)

A Novel Approach to the Management of Neonatal Diabetes Using Sensor-Augmented Insulin Pump Therapy With Threshold Suspend Technology at Diagnosis
por: Marin, Monica T., et al.
Publicado: (2016)

Insulin Augmentation of Glucose-Stimulated Insulin Secretion Is Impaired in Insulin-Resistant Humans
por: Halperin, Florencia, et al.
Publicado: (2012)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes
por: Mehta, Sanjeev N., et al.
Publicado: (2021)

Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197–1204
por: Buckingham, Bruce A., et al.
Publicado: (2015)

SAT-641 Self-Reported Psychological Stress and Glucose Variability in Type 1 Diabetes on Sensor Augmented Pump over 5 Weeks
por: Kaur, Ravinder Jeet, et al.
Publicado: (2020)

Gland Suspension Improves Breast Augmentation Outcomes
por: Andjelkov, Katarina, et al.
Publicado: (2018)

Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study
por: Calles-Escandón, Jorge, et al.
Publicado: (2018)

Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial
por: Davis, Georgia M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p4688qj8jo94gr8mq2nderu1g3